Skip to content

Effects of acupuncture of the sphenopalatine ganglion combined with acupoint paste at the time of the solar terms on allergic rhinitis.

Effects of acupuncture of the sphenopalatine ganglion combined with acupoint paste at the time of the solar terms on allergic rhinitis: a Randomized Controlled Trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006775
Enrollment
Unknown
Registered
2022-11-14
Start date
2022-11-21
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis

Interventions

Control group:Conventional acupuncture
Treatment group:acupuncture of the sphenopalatine ganglion combined with acupoint paste at the time of the solar terms

Sponsors

Guilin Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1)Patients with a diagnosis of allergic rhinitis.(2)Subjects aged between 18 and 70 years.(3)Patients who volunteered to be tested and signed the informed consent form.(4)Patients not participating in other clinical trials.(5)Anyone who meets the diagnostic criteria for the disease and excludes the following exclusion criteria will be included in the trial.

Exclusion criteria

Exclusion criteria: (1)Patients who do not meet the diagnosis of allergic rhinitis.(2)Patients who are unable and/or incapable of understanding and/or carrying out this treatment programme.(3)Subjects aged less than 18 years or more than 70 yearsPregnant or lactating women.(4)Patients with severe allergic and infectious skin diseases, hemorrhagic diseases (such as thrombocytopenic purpura, haemophilia, etc.), poor blood glucose control in diabetes, severe diseases of important organs such as heart, liver, lung and kidney, or mental and psychological diseases.(5)Patients who have used steroids and antihistamines, antibiotics, decongestants, etc. within 1 week; those who have received specific immunotherapy or regular hormone therapy within 1 year.(6)Patients who cannot undergo this study protocol due to acupuncture site infection or scarring.(7)Patients who are unable to adhere to treatment and review as required..

Design outcomes

Primary

MeasureTime frame
Total symptom scores;

Secondary

MeasureTime frame
Average skin temperature of nasal region;Total sign scores;

Countries

China

Contacts

Public ContactYuxuan Li
9366955@qq.com18007873751

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026